IDL Diagnostics recently met with CLIA partner Zecen, and its Chinese distributors Vastec, Sysmex and Fosun, to discuss market opportunities and portfolio development.
Discussions highlighted China’s national pricing-code framework, expected to be implemented by the end of 2026. This could reduce regional access barriers for TPS and support higher sales volumes over time.
The visit also covered preparations for UBC and TK1 launches in 2027, subject to regulatory approvals, and potential international expansion through Zecen’s CLIA platforms.
